Aripiprazole-Induced Neutropenia in a Seven Year-Old Male: A Case Report

Muhammad Hassan Majeed1, Ali Ahsan Ali2

  • 1Department of Psychiatry, Quinnipiac University.

Cureus
|October 17, 2017
PubMed

Insights

Aripiprazole, an antipsychotic, can rarely cause neutropenia (low white blood cell count) in children. This case report highlights the importance of monitoring absolute neutrophil count (ANC) in pediatric patients taking aripiprazole.

Area of Science:

  • Pediatric Hematology
  • Neuropharmacology
  • Clinical Toxicology

Background:

  • Second-generation antipsychotics are known to cause blood dyscrasias.
  • Aripiprazole is generally considered safe with rare hematological side effects.
  • Neutropenia is a serious potential adverse effect requiring vigilant monitoring.

Observation:

  • A seven-year-old male developed acute neutropenia within a week of initiating aripiprazole therapy.
  • The patient's absolute neutrophil count (ANC) normalized spontaneously after discontinuation of aripiprazole.
  • This represents the first reported instance of leukopenia linked to aripiprazole in pediatric patients.

Findings:

  • Aripiprazole can induce acute neutropenia in the pediatric population.
  • Discontinuation of aripiprazole led to the recovery of neutrophil counts.
  • Early detection and intervention are crucial for managing aripiprazole-induced neutropenia.

Implications:

  • Clinicians should consider periodic monitoring of ANC in children prescribed aripiprazole.
  • Awareness of this rare but potentially lethal side effect is critical for patient safety.
  • This case underscores the need for careful hematological surveillance in pediatric patients on antipsychotic medications.